BlackRock Inc. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,574,506
-14.8%
8,191,502
+6.3%
0.00%0.0%
Q2 2023$28,830,588
+7.0%
7,708,713
-4.1%
0.00%0.0%
Q1 2023$26,939,816
-30.3%
8,041,736
+0.1%
0.00%0.0%
Q4 2022$38,641,481
-13.7%
8,033,572
+2.1%
0.00%
-50.0%
Q3 2022$44,789,000
-14.8%
7,871,121
+6.3%
0.00%0.0%
Q2 2022$52,594,000
+10.0%
7,407,542
+11.8%
0.00%
+100.0%
Q1 2022$47,830,000
-7.5%
6,624,693
+14.6%
0.00%0.0%
Q4 2021$51,684,000
-64.4%
5,781,197
+39.8%
0.00%
-75.0%
Q3 2021$145,035,000
+93.4%
4,136,801
+18.5%
0.00%
+100.0%
Q2 2021$74,985,000
+12.9%
3,490,963
+224.6%
0.00%0.0%
Q1 2021$66,412,000
+20.8%
1,075,504
-18.3%
0.00%0.0%
Q4 2020$54,975,0001,315,8300.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$4,712,40033.11%
BML Capital Management, LLC 2,236,239$8,363,5347.52%
TANG CAPITAL MANAGEMENT LLC 3,026,455$11,318,9421.67%
Stonepine Capital Management, LLC 752,088$2,812,8091.02%
Bain Capital Life Sciences Investors, LLC 2,485,638$9,296,2860.96%
CM Management, LLC 250,000$9350.91%
EcoR1 Capital, LLC 6,995,861$26,164,5200.64%
Cormorant Asset Management, LP 1,547,181$5,786,4570.32%
SECTORAL ASSET MANAGEMENT INC 501,537$1,875,7480.31%
Auour Investments LLC 177,000$661,9800.28%
View complete list of ATEA PHARMACEUTICALS INC shareholders